List of Pharma Portal Customers
APPS RUN THE WORLD
6701 Koll Center Parkway, Suite 250,
Pleasanton, 94566 , FL,
United States
Pleasanton, 94566 , FL,
United States
1 305-256-3311
Professional Services
100
$5M
Since 2010, our global team of researchers has been studying Pharma Portal customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Pharma Portal for Blockchain Platform from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Pharma Portal for Blockchain Platform include: Cardinal Health, a United States based Healthcare organisation with 53084 employees and revenues of $222.58 billion, Pfizer, a United States based Life Sciences organisation with 81000 employees and revenues of $63.63 billion, Novartis, a Switzerland based Life Sciences organisation with 75883 employees and revenues of $51.72 billion, Sonoco Products Company, a United States based Manufacturing organisation with 28000 employees and revenues of $5.31 billion and many others.
Contact us if you need a completed and verified list of companies using Pharma Portal, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Pharma Portal customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Cardinal Health | Healthcare | 53084 | $222.6B | United States | In-House Applications | Pharma Portal | Blockchain Platform | 2021 | Chronicled |
In 2021 Cardinal Health partnered with Chronicled to deploy a MediLedger blockchain-powered Pharma Portal as a Blockchain Platform to improve pharmaceutical chargeback accuracy and enhance connectivity between suppliers and customers in the United States. The engagement focused on embedding immutable transaction records and validation controls into Cardinal Health environments to support more reliable chargeback processing across commercial channels.
The Pharma Portal deployment implemented ledger-based transaction recording, reconciliation logic, and automated dispute flagging consistent with Blockchain Platform capabilities for provenance and validation. Configuration work included modeling chargeback event schemas, establishing identity and permission models for trading partners, and encoding business rules to trigger reconciliation workflows and notifications.
Integrations connected the Pharma Portal to Cardinal Health billing and chargeback systems and to internal portals and in-house applications to ingest supplier submissions and customer claims. Operational coverage emphasized United States supplier and customer connectivity, aligning supply chain and finance data flows to a shared transaction ledger for synchronized chargeback settlement.
Chronicled served as the implementation partner and supported onboarding and governance processes for trading partner identities and dispute escalation. Outcomes reported in the engagement centered on improved chargeback accuracy and reduced disputes through automated reconciliation and shared ledger visibility.
|
 |
Novartis | Life Sciences | 75883 | $51.7B | Switzerland | In-House Applications | Pharma Portal | Blockchain Platform | 2019 | Chronicled |
In 2019, Novartis integrated MediLedger blockchain capabilities into its in-house Pharma Portal as part of participation in the MediLedger DSCSA pilot focused on interoperable track and trace and product verification across the pharmaceutical supply chain. The Pharma Portal implementation is described as a Blockchain Platform integration and was scoped to provide access to verification and chargeback related services within supply chain and regulatory compliance workflows.
Functional modules embedded in the Pharma Portal included serialization record access, interoperable product verification lookup services, and chargeback reconciliation endpoints, reflecting standard Blockchain Platform capabilities for immutable event recording and consensus based verification. Configuration work emphasized API exposure and user interface extensions in existing in-house applications so internal users could query MediLedger verification services and record serialized movement events.
Chronicled served as the system integrator for the MediLedger pilot integration into the Pharma Portal, enabling secure connectivity between Novartis internal systems and the consortium ledger. Operational coverage aligned with pharmaceutical supply chain functions and US prescription distribution channels under the DSCSA pilot, with the Pharma Portal acting as the internal access point to ledger based verification services.
Governance and rollout conformed to consortium and DSCSA compliance rules, driving process changes around standardized serialization data models, permissioned access controls, and event attestation workflows within the Pharma Portal. The implementation prioritized embedding Blockchain Platform verification capabilities into existing operational processes and in-house applications rather than replacing core enterprise systems.
|
 |
Pfizer | Life Sciences | 81000 | $63.6B | United States | In-House Applications | Pharma Portal | Blockchain Platform | 2019 | Chronicled |
In 2019, Pfizer participated in the MediLedger DSCSA pilot to support pharmaceutical supply-chain traceability and product verification in the United States, using the MediLedger network for saleable returns and related verification workflows, in collaboration with Chronicled. The engagement tied Pfizer systems to a Blockchain Platform and focused on enabling interoperable verification flows required under the Drug Supply Chain Security Act.
Pfizer integrated MediLedger-based verification into its internal Pharma Portal and other in-house applications to consume serialization and verification services for DSCSA compliance. Implementations centered on serialization data ingestion, transaction-level verification calls, and saleable returns workflows, with the Pharma Portal acting as the application layer that initiates and displays verification responses from the Blockchain Platform.
Architecturally the integration relied on the MediLedger network as the decentralized verification layer and Pfizer in-house applications as the consumer layer, with API and adapter style interfaces inferred to mediate serialization lookups and cryptographic verification requests. Operational scope was explicitly the United States prescription supply chain, impacting supply-chain operations, returns management, and regulatory compliance teams that routed verification and disposition decisions through the Pharma Portal.
Governance and rollout were conducted within the MediLedger pilot framework, aligning standardized verification workflows and data exchange rules across participating manufacturers and trading partners, with Chronicled participating as the network implementation partner. The project was positioned to enable DSCSA-aligned serialization and product verification through Pfizers Pharma Portal integration with the Blockchain Platform, without asserting specific operational outcomes beyond the stated compliance objective.
|
 |
|
Manufacturing | 28000 | $5.3B | United States | In-House Applications | Pharma Portal | Blockchain Platform | 2022 | n/a |
|
Showing 1 to 4 of 4 entries
Buyer Intent: Companies Evaluating Pharma Portal
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Pharma Portal. Gain ongoing access to real-time prospects and uncover hidden opportunities.
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||
FAQ - APPS RUN THE WORLD Pharma Portal Coverage
Pharma Portal is a Blockchain Platform solution from In-House Applications.
Companies worldwide use Pharma Portal, from small firms to large enterprises across 21+ industries.
Organizations such as Cardinal Health, Pfizer, Novartis and Sonoco Products Company are recorded users of
Pharma Portal for Blockchain Platform.
Companies using Pharma Portal are most concentrated in Healthcare, Life Sciences and Manufacturing, with adoption spanning over 21 industries.
Companies using Pharma Portal are most concentrated in United States and Switzerland, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Pharma Portal across Americas, EMEA, and APAC.
Companies using Pharma Portal range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 100%.
Customers of Pharma Portal include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified Pharma Portal customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Blockchain Platform.